Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMarstons Regulatory News (MARS)

Share Price Information for Marstons (MARS)

Share Price is delayed by 15 minutes
Get Live Data
50.10    -0.80 (-1.57%)
Bid:
50.20
Ask:
50.80
Spread: 0.60 (1.195%)
Market Cap: £317.06m
MARS Live PriceLast checked at - London Stock Exchange

Intraday Marstons Share Chart

COVID-19 Update re: securitisation waiver granted

20 Apr 2020 07:00

RNS Number : 1169K
Marston's PLC
20 April 2020
Β 

20 April 2020

Β 

MARSTON'S PLC

("Marston's" or "the Group")

Β 

COVID-19 Update re: securitisation waiver granted

Β 

Marston's provides the following update in light of the COVID-19 virus.

We continue to take an extremely prudent approach in our management of the business during this period of unprecedented uncertainty, the timescale of which remains unclear pending further guidance from the UK Government as to how, and when, the current state of much reduced social activity can be relaxed and pubs allowed to re-open.

Β 

In addition to the actions which have been taken to reduce the Group's overall cost base, outlined in our previous update on 18 March, Marston's Issuer PLC has also taken the precautionary measure of securing a waiver of a breach that might arise under the 30 day suspension of business and operations provision under the terms of the Group's secured funding platform. The waiver has been granted until 29 May 2020 with an automatic extension to 15 June 2020 in certain circumstances.

Β 

The Group is also reviewing whether there is a need to consult with bondholders about further possible covenant waiversΒ under the secured funding platform in light of the impact of the UK Government's measures on the business.

Β 

Β 

Β 

ENQUIRIES:

Marston's PLC Tel: 01902 329516

Instinctif Partners

Ralph Findlay, Chief Executive Officer

Justine Warren Tel: 07785 555692

Andrew Andrea, Chief Financial and Corporate Development Officer

Matthew Smallwood Tel: 07831 379122

Β 

NOTES TO EDITORS

Β· Marston's is a leading pub operator and independent brewer.

Β· It has an estate of around 1,400 pubs situated nationally, comprising managed, franchised and leased pubs.

Β· It is the UK's leading brewer of premium cask and packaged ales, including Marston's Pedigree, Wainwright, Lancaster Bomber and Hobgoblin. The beer portfolio also includes Banks's, Jennings, Wychwood, Ringwood, Brakspear and Mansfield beers. Marston's has added Bombardier, Courage and McEwan's to its brand portfolio most recently, as well as a range of licensed brands including Young's, Founders and Estrella Damm.

Β· Marston's employs around 14,000 people.

Β 

Β 

Β 

Β 

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
Β 
END
Β 
Β 
UPDKKCBBKBKBOQD
Date   Source Headline
19th Jun 20127:00 amRNSInterests of Directors
1st Jun 201211:43 amRNSTotal Voting Rights
25th May 20122:14 pmRNSHolding(s) in Company
24th May 20124:16 pmRNSHolding(s) in Company
22nd May 20127:00 amRNSDirector/PDMR Shareholding
17th May 20127:00 amRNSInterim Results
1st May 20122:01 pmRNSTotal Voting Rights
2nd Apr 201211:35 amRNSTotal Voting Rights
29th Mar 20127:00 amRNSAnalyst Visit
15th Mar 20128:12 amRNSDirector/PDMR Shareholding
14th Mar 20127:00 amRNSTrading Update
1st Mar 20123:35 pmRNSTotal Voting Rights
14th Feb 201212:29 pmRNSHolding(s) in Company
1st Feb 20124:10 pmRNSTotal Voting Rights
1st Feb 20124:00 pmRNSDirector Declaration
27th Jan 20123:48 pmRNSResult of AGM
27th Jan 20127:00 amRNSAGM and Interim Management Statement
23rd Jan 20127:01 amRNSAppointment of Non-executive Director
10th Jan 20129:25 amRNSBlocklisting Interim Review
3rd Jan 20122:41 pmRNSTotal Voting Rights
20th Dec 20118:38 amRNSAnnual Information Update
16th Dec 20113:07 pmRNSAnnual Financial Report
16th Dec 201110:26 amRNSDirector/PDMR Shareholding
12th Dec 201110:18 amRNSHolding(s) in Company
5th Dec 201111:56 amRNSHolding(s) in Company
1st Dec 201111:37 amRNSDirector/PDMR Shareholding
1st Dec 201111:30 amRNSTotal Voting Rights
30th Nov 20117:00 amRNSFinal Results
7th Nov 20119:14 amRNSDirectorate Change
1st Nov 201111:27 amRNSTotal Voting Rights
5th Oct 201111:01 amRNSHolding(s) in Company
5th Oct 20117:00 amRNSTrading Statement
4th Oct 20112:01 pmRNSDirector/PDMR Shareholding
3rd Oct 201112:42 pmRNSTotal Voting Rights
3rd Oct 201110:04 amRNSDirectorate Change
1st Sep 20118:55 amRNSTotal Voting Rights
1st Aug 20113:20 pmRNSTotal Voting Rights
11th Jul 201112:13 pmRNSBlocklisting Interim Review
30th Jun 201111:25 amRNSTotal Voting Rights
24th Jun 20114:21 pmRNSDirector/PDMR Shareholding
6th Jun 20117:00 amRNSFranchise Accreditation
31st May 20111:38 pmRNSTotal Voting Rights
19th May 20117:00 amRNSInterim Results
28th Apr 20119:22 amRNSTotal Voting Rights
31st Mar 20113:05 pmRNSTotal Voting Rights
25th Mar 20113:35 pmRNSDirector/PDMR Shareholding
16th Mar 20117:00 amRNSTrading Update
28th Feb 20112:19 pmRNSTotal Voting Rights
24th Feb 201111:32 amRNSDirector/PDMR Shareholding
17th Feb 20112:09 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.